Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 4486 AL 4500

Nose-to-brain drug delivery for the treatment of Alzheimer's disease: current advancements and challenges

A P, Agrawal M, Dethe MR, Ahmed H, Yadav A, Gupta U, Alexander A.

Expert Opin Drug Deliv. 2022 Jan;19(1):87-102. doi: 10.1080/17425247.2022.2029845. Epub 2022 Jan 28.

Chaperoning shape-shifting tau in disease

Ryder BD, Wydorski PM, Hou Z, Joachimiak LA.

Trends Biochem Sci. 2022 Apr;47(4):301-313. doi: 10.1016/j.tibs.2021.12.009. Epub 2022 Jan 17.

Mechanisms associated with the dysregulation of mitochondrial function due to lead exposure and possible implications on the development of Alzheimer's disease

Bandaru LJM, Ayyalasomayajula N, Murumulla L, Challa S.

Biometals. 2022 Feb;35(1):1-25. doi: 10.1007/s10534-021-00360-7. Epub 2022 Jan 20.

A closer look at the mycobiome in Alzheimer's disease: Fungal species, pathogenesis and transmission

Phuna ZX, Madhavan P.

Eur J Neurosci. 2022 Mar;55(5):1291-1321. doi: 10.1111/ejn.15599. Epub 2022 Feb 8.

The Impact of Uremic Toxins on Alzheimer's Disease

Zheng Y, Ji B, Chen S, Zhou R, Ni R.

Curr Alzheimer Res. 2022;19(2):104-118. doi: 10.2174/1567205019666220120113305.

Is more always better? Dose effect in a multidomain intervention in older adults at risk of dementia

Belleville S, Cloutier S, Mellah S, Willis S, Vellas B, Andrieu S, Coley N, Ngandu T; MAPT/DSA group.

Alzheimers Dement. 2022 Nov;18(11):2140-2150. doi: 10.1002/alz.12544. Epub 2022 Jan 20.

Marine Organisms as Alkaloid Biosynthesizers of Potential Anti-Alzheimer Agents

Lima E, Medeiros J.

Mar Drugs. 2022 Jan 15;20(1):75. doi: 10.3390/md20010075.

Mechanistic Link between Vitamin B12 and Alzheimer's Disease

Lauer AA, Grimm HS, Apel B, Golobrodska N, Kruse L, Ratanski E, Schulten N, Schwarze L, Slawik T, Sperlich S, Vohla A, Grimm MOW.

Biomolecules. 2022 Jan 14;12(1):129. doi: 10.3390/biom12010129.

Implication of Adult Hippocampal Neurogenesis in Alzheimer's Disease and Potential Therapeutic Approaches

Essa H, Peyton L, Hasan W, León BE, Choi DS.

Cells. 2022 Jan 15;11(2):286. doi: 10.3390/cells11020286.

Comparative Phosphoproteomics of Neuro-2a Cells under Insulin Resistance Reveals New Molecular Signatures of Alzheimer's Disease

Kim D, Jo YS, Jo HS, Bae S, Kwon YW, Oh YS, Yoon JH.

Int J Mol Sci. 2022 Jan 17;23(2):1006. doi: 10.3390/ijms23021006.

Post-Ischemic Brain Neurodegeneration in the Form of Alzheimer's Disease Proteinopathy: Possible Therapeutic Role of Curcumin

Pluta R, Furmaga-Jabłońska W, Januszewski S, Czuczwar SJ.

Nutrients. 2022 Jan 7;14(2):248. doi: 10.3390/nu14020248.

Multi-ancestry eQTL meta-analysis of human brain identifies candidate causal variants for brain-related traits

Zeng B, Bendl J, Kosoy R, Fullard JF, Hoffman GE, Roussos P.

Nat Genet. 2022 Feb;54(2):161-169. doi: 10.1038/s41588-021-00987-9. Epub 2022 Jan 20.

Classification of diseases with accumulation of Tau protein

Kovacs GG, Ghetti B, Goedert M.

Neuropathol Appl Neurobiol. 2022 Apr;48(3):e12792. doi: 10.1111/nan.12792. Epub 2022 Feb 9.

Potential of flavonoids as anti-Alzheimer's agents: bench to bedside

Kaur R, Sood A, Lang DK, Bhatia S, Al-Harrasi A, Aleya L, Behl T.

Environ Sci Pollut Res Int. 2022 Apr;29(18):26063-26077. doi: 10.1007/s11356-021-18165-z. Epub 2022 Jan 24.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias